New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes.
Launched by ASSIUT UNIVERSITY · Apr 4, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how new heart rhythm problems, known as cardiac arrhythmias, affect patients who are critically ill from sepsis, which is a severe infection that spreads throughout the body. The researchers want to understand what factors might predict these heart issues and what the outcomes are for patients who experience them.
To participate in this study, you need to be an adult aged 18 or older and have been admitted to the hospital with signs of sepsis. Unfortunately, those under 18, pregnant women, or individuals with a history of heart rhythm problems or previous heart surgeries won’t be eligible. If you decide to take part, you can expect to be closely monitored during your treatment in the critical care unit, and your health will be carefully evaluated to help the researchers learn more about how to manage these heart issues in septic patients. This study is not yet recruiting participants, so there will be further announcements about when it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient of 18 years old and above of both gender admitted with manifestation of sepsis.
- Exclusion Criteria:
- • Patients below 18 years old.
- • Pregnant females.
- • Patients with cardiac arrhythmia before admission in the critical unit.
- • Patients with previous cardiac surgery.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported